Pharmafile Logo

The future of dementia and the important role of healthcare communication in raising awareness

At Bedrock Healthcare Communication we are proud to help spread awareness of dementia with the ultimate goal to improve the lives of patients and carers

This week in the UK marks Dementia Action Week, a national eventorganised by the Alzheimer’s Society that sees the public coming together to take action to improve the lives of people affected by dementia.

Dementia is a growing challenge and has become one of the most important health and social care issues in the UK. Today there are approximately 850,000 people living with the disease in the UK and this number is predicted to double by 2040 with a current economic cost estimated at £23 billion a year and predicted to triple by 2040.

- PMLiVE

While Alzheimer’s disease it the most common and well-known cause of dementia, with over 10 million cases globally, it is not the only one. There are different diseases that can cause dementia. These involve protein build-up and/or reduced blood flow in the brain that ultimately cause a progressive cognitive decline that can manifest as memory loss, language deficit and changes in mood and behaviour, among others.

There are few existing treatments for dementia and research remains pivotal.Prescribers and patients would of course welcome more effective and longer-lasting symptomatic treatments. Patients would benefit most from a disease-slowing or modifying therapy but symptomatic treatments with improved clinical profiles would also make a difference to their lives.

Progress was made in February 2018, when the FDA released a draft guidance document categorising Alzheimer’s disease into stages that define preclinical and prodromal disease based on biomarker, cognitive, and functional attributes. This allows for an accelerated approval for treatments based on biomarkers that are reasonably likely to predict clinical benefit. While the pharmaceutical industry continues its search for treatments there is a need to educate healthcare professionals on the latest developments in biomarker research and how these can be used in clinical practice.

At Bedrock Healthcare Communications, we are proud and passionate to share our expertise in neuroscience. We in medical communication across neurological diseases every day, and this Dementia Action Week we are committed to help raise awareness and truly make a difference to all those affected by this condition.

If you share our passion, visit bedrock-health.com and start a conversation with us.

REFERENCES:

This content was provided by Bedrock Healthcare Communications

Company Details

 Latest Content from  Bedrock Healthcare Communications 

Bedrock creates waves

The Bedrock team were awash with ideas at their summer watersports and BBQ event. All were Bravely Bedrock in a host of activities – including wakeboarding, paddle boarding and taming...

Bedrock LEAPs to new heights

What do our future leaders say about LEAP?

Bedrock Group strengthens its senior team

Bedrock strengthen its management team with the recruitment of two senior roles

A postcard from Cannes

This week sees the annual Cannes Lions International Festival of Creativity, bringing together leading creative talent from across the globe to learn, share and inspire each other. Until recently, pharmaceuticals...

A variety of backgrounds, a unified purpose

How did Bedrock become Bedrock? We asked members of the Bedrock team how they found their way into the (somewhat hidden) world of medical communications, and what they love about...

Wanda Lesowiec did it. Could you?

How a background in pharma can mean a bright future in medical communications

Am I wrong to be apprehensive about gene therapy?

Is the introduction of gene therapy going to be smooth sailing? Origin's Strategic Solutions Director, Su Smith, shares her thoughts.

Bedrock Group announces the launch of Origins, a health experience research company

Bedrock Group is proud to announce the launch of Origins, a health experience research company.

Artificial Intelligence: a new character in the storytelling of drug development and discovery?

Written by Edward Jones, Junior Medical Writer. Bedrock is dedicated to creating valuable and powerful stories to engage audiences that drive an improvement in the provision of health. This focus...

The playbook of a ‘reluctant creative’

Are we all capable of being creative?